Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: Insights from the ODYSSEY OUTCOMES trial

Rafael Diaz, Qian H. Li, Deepak L. Bhatt, Vera A. Bittner, Marie T. Baccara-Dinet, Shaun G. Goodman, J. Wouter Jukema, Takeshi Kimura, Alexander Parkhomenko, Robert Pordy, Zeljko Reiner, Matthew T. Roe, Michael Szarek, Hung Fat Tse, Harvey D. White, Doron Zahger, Andreas M. Zeiher, Gregory G. Schwartz, Ph Gabriel Steg